AKBA — AKEBIA THERAPEUTICS INC

Ownership history in EntryPoint Capital, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in AKEBIA THERAPEUTICS INC (AKBA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.08% (2025 Q4)
Avg. % of fund
0.05%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 127,501 +83,050 +186.8% 0.08% $205K $1.61
2025 Q3 ADDED 44,451 +3,455 +8.4% 0.05% $121K $2.73
2025 Q2 ADDED 40,996 +30,406 +287.1% 0.07% $149K $3.64
2024 Q1 INITIATED 10,590 — — 0.02% $19K —
% of Fund (quarterly)    AKBA price (monthly, adj. close)

Other funds also holding AKBA

As of 2025 Q4 — sorted by position size

Nantahala Capital Management, LLC 3Y 7Y 0.11% Orchard Capital Management, LLC 3Y 0.07% OXFORD ASSET MANAGEMENT LLP 3Y 7Y 0.07% nVerses Capital, LLC 0.04% Round Rock Advisors LLC 3Y 0.04% Hennion & Walsh Asset Management, Inc. 3Y 0.03% NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 3Y 7Y 0.02% XTX Topco Ltd 3Y 0.02% Empirical Asset Management, LLC 3Y 0.02% Graham Capital Management, L.P. 3Y 7Y 0.01%
← Back to EntryPoint Capital, LLC Holdings